Delivery Order SPE2DB20D3103-SPE2DB23FP0M0
Award Date 7/19/23
Potential Completion Date 7/20/23
Potential Value $34K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical, a major medical supply chain organization within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,100.61 with a firm fixed price, and the ultimate...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $29,174.58 and is a Firm Fixed Price Delivery Order that runs through September 19, 2023. The award was made without any set-aside designation, indicating full and open competition....
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to support Defense Logistics Agency (DLA) Troop Support Medical operations. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution firm. The award, valued at $6,320.92, is a firm-fixed price delivery order contract with a completion date of January 26, 2024. This contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion in 60-count packages to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,008.44 and is a firm fixed-price delivery order with a completion date of December 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $8,064.14 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 17, 2024 with a completion date of July 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical...
- This federal contract award is for the delivery of 4566305582 Cyclosporine 0.05% eye emulsion in 60 count packages. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,888.00 and a completion date of November 4, 2024. It is a Delivery Order under a Firm Fixed Price contract type. The contract is not designated with a...
- This federal contract award is for the delivery of cyclosporine 0.05% eye emulsion 60s to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $4,114.03 on May 6, 2025. The contract has a firm fixed price and an ultimate completion date of May 7, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 26, 2024, with a ceiling value of $2,737.21 and a completion date of June 27, 2024. The contract is a delivery order, with a firm fixed-price pricing type, and is not designated with a set-aside requirement....
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion 60s, a specialized pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,546.26 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of October 17, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...